Company Profiles

driven by the PitchBook Platform

SpectraGenetics

SpectraGenetics
2003 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$2.75M LATEST DEAL AMOUNT
$85k TOTAL AMOUNT RAISED
Description

Provider of technologies for drug discovery and development. The company's technologies allow researchers to determine when a gene is expressed and to visualize in real time the expression, cellular localization or activation of proteins in living cells.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Primary Office
2403 Sidney Street
Suite 255
Pittsburgh, PA 15203
United States
+1 (412) 488-9350
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SpectraGenetics’s full profile, request a free trial.

SpectraGenetics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 04-Apr-2012 $2.75M $85k Completed Startup
1. Early Stage VC 0000 0000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

SpectraGenetics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Idea Foundry Accelerator/Incubator Minority 000 0000 000000 0
Innovation Works Venture Capital Minority 000 0000 000000 0
Pittsburgh Life Sciences Greenhouse Venture Capital Minority 000 0000 000000 0

SpectraGenetics Executive Team (1)

Name Title Board
Seat
Contact
Info
Reid Asbury Ph.D Chief Executive Officer